News & Events
People with MS who have additional health conditions are more likely to experience relapses
Canadian study finds people with MS who have additional health conditions face a greater risk of having…
Argentina presents awards to MS researchers
The Association for the Fight Against MS (ALCEM) presents the Miguel Pablo Gallardo award and the Proyecto…
Tawasol – Dec 2017 issue
Latest news from 17 organisations in the Arab region
First treatment for early primary progressive MS approved in Europe
The European Commission has approved the first disease-modifying therapy, ocrelizumab, for early primary progressive MS (PPMS).
Research Australia presents award to developer of world’s largest MS database
Helmut Butzkueven, who led the development of MSBase with support from MS Research Australia, has received the…
MS organisations across Latin America gather in Mexico for third annual meeting
Third annual meeting (Encuentro) brings together MS organisations from 16 Latin American countries to share learnings and…
MS organisations and health professionals gather in Dubai for MENACTRIMS 2017
More than 900 health professionals and representatives from 38 countries gathered in Dubai for MENACTRIMS 2017, which…
2017: a pivotal year for the MSIF movement
This year marked the 50th anniversary of the MS International Federation, giving us a valuable opportunity to…
Study shows taking MS medications as directed is better for overall health
Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health
New study shows cold water in the mouth can reduce heat sensitivity in MS
Cold water in the mouth can help reduce heat sensitivity, a common symptom of MS.
Disappointing results from CCSVI treatment trial
Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that…
Discovering how immune cells get into the brain in MS
Study reveals important mechanism that allows immune cells to attack myelin in MS